A carregar...
PD-L1 in melanoma: facts and myths
The use of monoclonal antibodies that block immunologic checkpoints that would otherwise mediate the adaptive immune resistance have paved the way in cancer treatment. There is evidence that blocking the PD-1/PD-L1 axis is a strategy of overriding importance in the treatment of patients with metasta...
Na minha lista:
| Publicado no: | Melanoma Manag |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6096437/ https://ncbi.nlm.nih.gov/pubmed/30190888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt-2016-0013 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|